We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Experimental Colitis as a Promoter in Large-Bowel Tumorigenesis

Patrick F. Hagihara, MD
Arch Surg. 1982;117(10):1304-1307. doi:10.1001/archsurg.1982.01380340036009.
Text Size: A A A
Published online


• To study the effect of acetic acid colitis on 1,2-dimethylhydrazine-induced colon tumorigenesis, Fischer 344 male rats, 10 weeks of age, were divided into three groups: one receiving 5% acetic acid enema (subgroup 1a); one receiving 10% acetic acid enema (subgroup 1b); and one not receiving acetic acid enema (group 2). Colitis developed in rats in groups 1a and 1b, resulting in early death in some cases. Rats of all three groups received the same subcutaneous dose of dimethylhydrazine given once a week for 20 weeks starting at 11 weeks of age; they were killed at 31 weeks after the first dimethylhydrazine injection. The percentage of animals having tumors in the large bowel was greatest in subgroup 1b and least in group 2. The mean number of largebowel tumors per animal in which large-bowel tumors had developed was determined in each group. The mean number of subgroup 1b was greater than that of group 2 and also greater than that of groups 1a and 2 combined. The results of the study suggest that colonic mucosal injury may render the colonic epithelium susceptible to tumor induction by carcinogens in the fecal stream.

(Arch Surg 1982;117:1304-1307)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.